| HOME >> BIOLOGY >> TECHNOLOGY |
-- Company Maintains Full Year Guidance
SHENZHEN, China, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- Mindray
Medical International Limited (NYSE: MR), a leading developer, manufacturer
and marketer of medical devices worldwide today announced its selected
unaudited financial results for the second quarter ended June 30, 2008.
During the quarter, Mindray successfully completed the acquisition of
Datascope Corp.'s patient monitoring business. The financial results
reported below include the results of operations of the patient monitoring
business acquired from Datascope ("DPM") starting from May 1, 2008.
Highlights for Second Quarter 2008
-- Second quarter 2008 net revenues were US$145.7 million, an increase of
99.5% from US$73.0 million in the second quarter 2007.
-- Net revenues generated in international markets in the second quarter
2008 were US$87.8 million, an increase of 139.0% from US$36.7 million
in the second quarter 2007.
-- Net revenues generated in China in the second quarter 2008 were US$57.9
million, an increase of 59.4% from US$36.3 million in the second
quarter 2007.
-- Non-GAAP operating profit, as defined below, in the second quarter 2008
was US$40.0 million, a 68.5% increase from US$23.7 million in the
second quarter 2007. Second quarter 2008 GAAP operating profit was
US$27.8million.
-- Second quarter 2008 non-GAAP net income, as defined below, was US$35.2
million, an increase of 54.7% from US$22.8 million in the second
quarter 2007. Second quarter 2008 GAAP net income was US$24.1 million.
-- Second quarter 2008 non-GAAP diluted earnings per share, as defined
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved |